Trials / Completed
CompletedNCT01555957
Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis
Effect of Lipid Intake on Direct Hyperbilirubinemia in Late Preterm and Term Infants With Gastrointestinal Surgical Problems.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Rochester · Academic / Other
- Sex
- All
- Age
- 72 Hours
- Healthy volunteers
- Not accepted
Summary
The Investigators hypothesize that increased cumulative amount of lipid intake causes PNAC in late preterm and term neonates with major GI surgical disorders
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | intravenous lipid | intravenous given daily for 6 weeks |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2018-10-30
- Completion
- 2019-01-31
- First posted
- 2012-03-16
- Last updated
- 2020-12-03
- Results posted
- 2020-12-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01555957. Inclusion in this directory is not an endorsement.